Clopidogrel does not optimally inhibit platelet aggregation in patients undergoing percutaneous coronary intervention. Observations from the DEACON study

被引：0
|
作者：
Saucedo, JF
Aude, W
Garza, L
机构：
[1] Univ Oklahoma, HSC, Oklahoma City, OK USA
[2] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10L / 11L
页数：2
相关论文
共 50 条
  • [1] Effects of eptifibatide, bivalirudin and clopidogrel on platelet function in patients undergoing percutaneous coronary intervention. Final results of the DEACON study
    Saucedo, JF
    Thorn, B
    Aude, W
    Pacheco, R
    Shuler, S
    Matin, Z
    Gudapati, S
    Garza, L
    CIRCULATION, 2003, 108 (17) : 576 - 576
  • [2] Inhibition of platelet aggregation with eptifibatide, bivalirudin, and heparin in patients undergoing percutaneous coronary intervention receiving clopidogrel pretreatment (The PharmacoDynamic evaluation of angiomax, clopidogrel with or without INtegrilin [DEACON] study)
    Saucedo, JF
    Aude, W
    Pacheco, R
    Thorn, B
    Matin, Z
    Husain, K
    Garza, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (12): : 1453 - 1456
  • [3] Lack of early optimal inhibition of platelet aggregation with clopidogrel in patients undergoing percutaneous coronary intervention
    Saucedo, JF
    Gudapati, S
    Shuler, S
    Thorn, B
    Garza, L
    CIRCULATION, 2003, 108 (17) : 577 - 577
  • [4] Cangrelor Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention. Results of the CHAMPION PCI Study
    Preobrazhensky, D., V
    KARDIOLOGIYA, 2010, 50 (07) : 63 - 64
  • [5] IMPACT OF SMOKING ON PLATELET INHIBITION OF CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Liu Xiaoli
    Zhou Yujie
    Yang Qing
    Yang Shiwei
    Jia Dean
    HEART, 2010, 96 : A159 - A159
  • [6] Effect of clopidogrel and GPIIb/IIIa inhibitors on ADP-Induced platelet aggregation during percutaneous coronary intervention.
    Lasic, Z
    Kokolis, S
    Stogioglou, A
    Ilic, V
    Knezevic, D
    Mani, A
    Karatepe, M
    Aboufares, A
    Coplan, N
    Mehran, R
    Dangas, G
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 78I - 78I
  • [7] Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention
    Volpi, Elisabetta
    Giusti, Laura
    Ciregia, Federica
    Da Valle, Ylenia
    Giannaccini, Gino
    Berti, Sergio
    Clerico, Aldo
    Lucacchini, Antonio
    CLINICAL BIOCHEMISTRY, 2012, 45 (10-11) : 758 - 765
  • [8] Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention
    Zhu, Pei
    Tang, Xiao-Fang
    Song, Ying
    Zhang, Yin
    Gao, Li-Jian
    Gao, Zhan
    Chen, Jue
    Yang, Yue-Jin
    Gao, Run-Lin
    Xu, Bo
    Yuan, Jin-Qing
    PLATELETS, 2021, 32 (05) : 684 - 689
  • [9] Does diabetes mellitus increase clopidogrel resistance in patients undergoing percutaneous coronary intervention?
    Chirumamilla, A.
    Mehran, R.
    Kanwal, S.
    Cha, J. Y.
    Bond, T. F.
    Falkenstern, J. R.
    Wong, V.
    Fahy, M.
    Stone, G. W.
    Dangas, G.
    EUROPEAN HEART JOURNAL, 2010, 31 : 388 - 389
  • [10] Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention
    Sibbing, Dirk
    Busch, Gabriele
    Braun, Siegmund
    Jawansky, Stefan
    Schoemig, Albert
    Kastrati, Adnan
    Ott, Ilka
    von Beckerath, Nicolas
    EUROPEAN HEART JOURNAL, 2008, 29 (12) : 1504 - 1509
12345